Biotechnology
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.

$515.5M

Market Cap • 4/3/2025

2000

(25 years)

Founded

2008

(17 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Los Angeles

Headquarters • California